Methodist Hospital
September 30, 2021

Methodist Hospital is pleased to announce the appointment of Rachel Goldsmith as the new chief operating officer (COO) for Methodist Hospital and Methodist Children’s Hospital.

“I am greatly honored to join Methodist Hospital and Methodist Children’s Hospital as COO,” stated Goldsmith. “As a native San Antonian, I have always been in awe of the excellence in care that Methodist provides to the South Texas community and it will be an absolute privilege to support the organization in its mission of serving humanity to honor God.”

Goldsmith returns to Methodist Hospital after serving as COO for Methodist Hospital Northeast. Her strengths include both organizational/service line growth as well as employee engagement and relationship-building. During her tenure at Methodist Hospital Northeast, Goldsmith had oversight of the daily operations of all procedural, ancillary and support areas and staff of over 300 full-time employees. She led over $40 million construction projects, including a 30-bed inpatient unit, a hybrid operating suite, an electrophysiology lab, and the vertical addition of 3 parking garage levels, among others. Goldsmith was instrumental in developing a lung nodule program, spearheaded the design and construction of an outpatient surgery department, and implemented the opening of a new free-standing emergency room and plans for a new medical office building (MOB).

Having formerly served as Vice President of Operations, Business Development and Strategy for Methodist Hospital and Methodist Children’s Hospital, Goldsmith advanced the adult and pediatric cardiovascular service line through programmatic development, operational oversight, physician recruitment as well as quality and regulatory management.

“We are excited to welcome Rachel back to our campus as a valuable addition to our administration team,” commented Dan Miller, Chief Executive Officer for Methodist Hospital and Methodist Children’s Hospital. “Rachel brings a wealth of knowledge and experience in leading clinical expansions as well as construction projects that lend to growth and enhanced patient experiences. I look forward to the great things Rachel will help us achieve and the impact she’ll have on our organization and community.”

Rachel will begin her new executive leadership role November 1.